This paper analyses various factors involved in the determination of the cross-reactivity of autoantibodies in connective tissue diseases. We report the results of various studies of antigens and antibodies relating to this topic, and consider the possible role of cross-reactivity in the pathogenesis of some of the clinical manifestations of systemic autoimmune diseases.